With a passion for the importance of the patient voice in federal policy, Deidre has held several senior management and executive roles within the public health sector, as well as gaining invaluable experience in the not-for-profit space as former CEO of Multiple Sclerosis Australia.
Leading Crohn's & Colitis Australia since 2018, Leanne’s focus is on advocacy and delivering transformative healthcare services, drawing on her expertise in leadership, strategy, and governance. Under her leadership, underpinned by her passion for visibility in healthcare and patient empowerment, the team have pioneered support systems and championed quality care improvements for over 100,000 Australians living with IBD.
Crohn’s and Colitis Australia is a member of the Australian Patient Advocacy Alliance and Leanne joined the APAA Board in February 2023.
Carolyn is a dynamic and experienced professional, passionate about working with people to achieve outstanding organisational results underpinned by significant experience working across a range of industry sectors. Since joining IDFA in 2020, she has used her strong experience in strategic planning and implementation, project management, organisational change, and exceptional communication and interpersonal skills to lead IDFA in the health advocacy space.
IDFA is a member of the Australian Patient Advocacy Alliance and Carolyn joined the APAA Board in February 2023.
An extensive career largely as a leader in the not-for-profit sector encompassing senior executive and director roles including 5 years as CEO Asthma Australia and over 13 years as Managing Director / CEO at Kidney Health Australia. Anne also ran her own consulting business and was appointed CEO of Emerge Australia in 2021.
Emerge Australia is a member of the Australian Patient Advocacy Alliance and Anne joined the APAA Board in October 2024.
